Jordi Martínez

发表

Synthesis and mass spectroscopy kinetics of a novel ternary copper(II) complex with cytotoxic activity against cancer cells.

P. Escribá, E. Molins, V. Moreno, 2007, Journal of inorganic biochemistry.

Long-term hematological reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10% dimethylsulfoxide at -80 degrees C in a mechanical freezer.

P. Galan, Jordi Martínez, J. Besalduch, 2007, Haematologica.

Minerval induces apoptosis in Jurkat and other cancer cells

P. Escribá, X. Busquets, Silvia Terés, 2008, Journal of cellular and molecular medicine.

The Repression of E2F-1 Is Critical for the Activity of Minerval against Cancer

A. Dopazo, P. Escribá, Jordi Martínez, 2005, Journal of Pharmacology and Experimental Therapeutics.

Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval

P. Escribá, Silvia Terés, Jordi Martínez, 2005, Molecular Pharmacology.

Membrane Structure Modulation , PKC α Activation and Anti-Cancer Activity of Minerval

P. Escribá, Silvia Terés, Jordi Martínez, 2004 .

Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval.

P. Escribá, J. Casas, P. Kasprzyk, 2005, Molecular pharmacology.

Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma

J. Pons, Jordi Martínez, J. Besalduch, 2006, Leukemia & lymphoma.

Minerval induces apoptosis in Jurkat and other cancer cells

P. Escribá, X. Busquets, J. Casas, 2008, Journal of cellular and molecular medicine.

Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval

P. Escribá, J. Casas, P. Kasprzyk, 2005, Molecular Pharmacology.

Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma

S. Fernández de Mattos, Jordi Martínez, J. Rodríguez, 2007, Leukemia & lymphoma.

GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study

Jordi Martínez, A. Palacios, A. Gutiérrez, 2007, European journal of haematology.